首页> 外文期刊>Journal of Molecular Biology >Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
【24h】

Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.

机译:基于结构的设计和非淀粉样生成,双N-甲基化IAPP淀粉样蛋白核心序列作为IAPP淀粉样蛋白形成和细胞毒性抑制剂的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic amyloid is formed by the aggregation of the 37-residue islet amyloid polypeptide (IAPP) in type II diabetes patients and is cytotoxic. Pancreatic amyloid deposits are found in more than 95 % of type II diabetes patients and their formation is strongly associated with disease progression. IAPP amyloid forms via a conformational transition of soluble IAPP into aggregated beta-sheets. We recently identified IAPP(22-27) (NFGAIL) as a minimum length sequence sufficient to self-associate into beta-sheet-containing amyloid fibrils. Here, we have used the NFGAIL model of the IAPP amyloid core as a structural template to design non-amyloidogenic derivatives of amyloidogenic sequences of IAPP that are able to interact with the native sequences and inhibit amyloid formation. The design of the derivatives was based on a simple, structure-based minimalistic and selective N-methylation approach. Accordingly, a minimum number of two amide bonds on the same side of the beta-strand of the amyloid core was N-methylated. This was expected to eliminate the two intermolecular backbone NH to CO hydrogen bonds which are critical for the extension of the beta-sheet dimers into multimers and amyloid. Other beta-strand "contact sides" remained intact allowing for the derivatives to interact with the native sequences. Double N-methylated derivatives of amyloidogenic and cytotoxic partial IAPP sequences generated included F(N-Me)GA(N-Me)IL, NF(N-Me)GA(N-Me)IL, SNNF(N-Me)GA(N-Me)IL, and SNNF(N-Me)GA(N-Me)ILSS and were found to be devoid of beta-sheet structure, amyloidogenicity and cytotoxicity according to Fourier transform-infrared spectroscopy (FT-IR), Congo red (CR) staining, electron microscopy (EM), and cell viability tests. The derivatives were able to interact with the native sequences and inhibit amyloid formation as shown by circular dichroism spectroscopy (CD), FT-IR and EM. Moreover, SNNF(N-Me)GA(N-Me)ILSS inhibited cytotoxicity of SNNFGAILSS and is thus the first reported inhibitor of IAPP amyloid formation and cytotoxicity. Our results demonstrate the validity of the design approach for IAPP and suggest that it may find application in understanding the structural features of amyloid formation and in the development of inhibitors of amyloid formation and cytotoxicity of other amyloidogenic polypeptides as well.
机译:胰腺淀粉样蛋白是由II型糖尿病患者中37个残基的胰岛淀粉样蛋白多肽(IAPP)聚集形成的,具有细胞毒性。超过95%的II型糖尿病患者发现了胰腺淀粉样蛋白沉积物,其形成与疾病进展密切相关。 IAPP淀粉样蛋白通过可溶性IAPP构象转变为聚集的β-折叠而形成。我们最近确定了IAPP(22-27)(NFGAIL)作为足以自缔合到包含β-折叠的淀粉样蛋白原纤维的最小长度序列。在这里,我们已使用IAPP淀粉样蛋白核心的NFGAIL模型作为结构模板来设计IAPP的淀粉样蛋白产生序列的非淀粉样蛋白衍生物,该衍生物能够与天然序列相互作用并抑制淀粉样蛋白的形成。衍生物的设计基于简单的,基于结构的简约和选择性的N-甲基化方法。因此,淀粉样蛋白核的β链的同一侧的最少两个酰胺键被N-甲基化。预期这消除了两个分子间主链NH至CO氢键,这对于将β-折叠二聚体延伸成多聚体和淀粉样蛋白至关重要。其他β链“接触面”保持完整,允许衍生物与天然序列相互作用。生成淀粉样蛋白和细胞毒性部分IAPP序列的双N甲基化衍生物包括F(N-Me)GA(N-Me)IL,NF(N-Me)GA(N-Me)IL,SNNF(N-Me)GA( N-Me)IL和SNNF(N-Me)GA(N-Me)ILSS,根据傅立叶变换红外光谱(FT-IR),刚果红被发现不含β-折叠结构,淀粉样变性和细胞毒性(CR)染色,电子显微镜(EM)和细胞活力测试。衍生物能够与天然序列相互作用并抑制淀粉样蛋白的形成,如圆二色性光谱(CD),FT-IR和EM所示。此外,SNNF(N-Me)GA(N-Me)ILSS抑制SNNFGAILSS的细胞毒性,因此是第一个报道的IAPP淀粉样蛋白形成和细胞毒性抑制剂。我们的结果证明了IAPP设计方法的有效性,并暗示它可能在理解淀粉样蛋白形成的结构特征以及开发淀粉样蛋白抑制剂和其他淀粉样蛋白产生的多肽的细胞毒性方面有应用价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号